Three‐in‐One Peptide Prodrug with Targeting, Assembly and Release Properties for Overcoming Bacterium‐Induced Drug Resistance and Potentiating Anti‐Cancer Immune Response
Advanced Materials · 2024-06 · 36 (23)
DOI: 10.1002/adma.202312153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 13.03.2024. Verfasst von Ge Gao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Institute, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, Jiangsu, 221004, China. Hauptthemen laut MEDLINE: Prodrugs, Antineoplastic Agents, Colorectal Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
The presence of bacteria in tumor results in chemotherapeutic drug resistance and weakens the immune response in colorectal cancer. To overcome bacterium‐induced chemotherapeutic drug resistance and potentiate antitumor immunity, herein a novel molecule Biotin‐Lys(SA‐Cip‐OH)‐Lys(SA‐CPT)‐Phe‐Phe‐Nap ( Biotin‐Cip‐CPT‐Nap ) is rationally designed containing four functional motifs (i.e., a biotin motif for targeting, Phe‐Phe(‐Nap) motif for self‐assembly, ciprofloxacin derivative (Cip‐OH) motif for antibacterial effect, and camptothecin (CPT) motif for chemotherapy). Using the designed molecule, a novel strategy of intracellular enzymatic nanofiber formation and synergistic antibacterium‐enhanced chemotherapy and immunotherapy is achieved. Under endocytosis mediated by highly expressed biotin receptor in colorectal cancer cell membrane and the catalysis of highly expressed carboxylesterase in the cytoplasm, this novel molecule can be transformed into Biotin‐Nap , which self‐assembled into nanofibers. Meanwhile, antibiotic Cip‐OH and chemotherapeutic drug CPT are released, overcoming bacterium‐induced drug resistance and enhancing the therapeutic efficacy of immunotherapy towards colorectal cancer. This work offers a feasible strategy for the design of novel multifunctional prodrugs to improve the efficiency of colorectal cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Institute, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, Jiangsu, 221004, China.
- Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, 99 Huaihai Road, Xuzhou, Jiangsu, 221002, China.
- Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, Jiangsu, 221004, China.
- School of Medical Imaging, Xuzhou Medical University, 209 Tongshan Road, Xuzhou, Jiangsu, 221004, China.
- State Key Laboratory of Bioelectronics, School of Biological Science and Medical Engineering, Southeast University, Nanjing, Jiangsu, 210096, China.
- Department of General Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, China.
ORCID-Profile: Ge Gao
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Xuzhou Medical University Excellent Talent Research Start-up Fund
Zitieren
APA
Gao, G., Jiang, Y. W., Chen, J., Xu, X., Sun, X., Xu, H., Liang, G., Liu, X., Zhan, W., Wang, M., Xu, Y., Zheng, J., & Wang, G. (2024). Three‐in‐One Peptide Prodrug with Targeting, Assembly and Release Properties for Overcoming Bacterium‐Induced Drug Resistance and Potentiating Anti‐Cancer Immune Response. Advanced Materials, 36(23). https://doi.org/10.1002/adma.202312153
Vancouver
Gao G, Jiang YW, Chen J, Xu X, Sun X, Xu H, et al. Three‐in‐One Peptide Prodrug with Targeting, Assembly and Release Properties for Overcoming Bacterium‐Induced Drug Resistance and Potentiating Anti‐Cancer Immune Response. Advanced Materials. 2024;36(23). doi:10.1002/adma.202312153
BibTeX
@article{Gao2024,
author = {Gao, Ge and Jiang, Yao-Wen and Chen, Jiaxuan and Xu, Xiaodi and Sun, Xianbao and Xu, Haidong and Liang, Gaolin and Liu, Xiaoyang and Zhan, Wenjun and Wang, Meng and Xu, Yixin and Zheng, Junnian and Wang, Gang},
title = {Three‐in‐One Peptide Prodrug with Targeting, Assembly and Release Properties for Overcoming Bacterium‐Induced Drug Resistance and Potentiating Anti‐Cancer Immune Response},
journal = {Advanced Materials},
year = {2024},
volume = {36},
number = {23},
doi = {10.1002/adma.202312153}
}
EUVIMED